Want to join the conversation?
Bill Bonello of Craig-Hallum asks about the long-term growth of Covance and whether $LH can be sustainable 10% plus EPS growth. CEO David King said $LH expects long-term revenue growth for the Diagnostics business to be low to mid single digits and for the Covance business to be mid to higher single digits consistently over time.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)